Humacyte Inc-cw27 (HUMAW) 13F Filing Data & Analysis (Q2 2026)

HUMAW ranks #10294 out of 37507 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

HUMAW is a disclosed holding of Israel Englander (Millennium Management), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

9 institutions disclose a position in HUMAW, but none treat it as a major bet — even LPL Financial LLC, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

LPL Financial LLC has trimmed its HUMAW position for two straight quarters, cutting it by $22.0K while still holding $2.3K.

HUMAW reported a net loss of $96.7M over the trailing twelve months.

• Not yet profitable — net loss of $96.7M over the trailing twelve months
• Revenue grew 159.3% year over year
• Net income declined year over year, from -$58.7M to -$96.7M
• Operating cash flow was negative, using $105.0M in cash
• Current ratio of 3.69x — enough short-term assets to cover short-term liabilities
• Liabilities run 36.43x equity — a highly leveraged balance sheet worth noting